Our technology gives failed drug molecules a second chance.

Uncategorized

Construction of Nanoform’s GMP manufacturing plant rapidly progresses

PRESS RELEASE 05 March 2019 Construction of Nanoform’s GMP manufacturing plant rapidly progresses Helsinki, Finland – Nanoform, an innovative drug enabling nanotechnology company, has announced significant progress in the construction of its new 600m2 GMP manufacturing plant, located at Cultivator II in Viikki Life Science Park, Finland. These important advancements in the project will enable …

Construction of Nanoform’s GMP manufacturing plant rapidly progressesRead More »

07.01.2019 Nanoform significantly strengthens commercial organisation with Chief of Business Operations appointment

PRESS RELEASE 7 January 2019 Nanoform significantly strengthens commercial organisation with Chief of Business Operations appointment Helsinki, Finland – Nanoform, an innovative drug enabling nanotechnology company, has appointed Dr Gonçalo Rebelo de Andrade as Chief of Business Operations. The newly created role will significantly strengthen Nanoform’s commercial organisation and continue its rapid growth through international …

07.01.2019 Nanoform significantly strengthens commercial organisation with Chief of Business Operations appointmentRead More »